News


ExpreS2ion will be present at the following events in November

BioEurope 2015 November 2–4, 2015, Munich, Germany http://www.ebdgroup.com/bioeurope/media/about_conf.php Is your project being slowed down by protein manufacturing challenges? Try ExpreS2, a virus-free insect cell expression system, easy to scale and regulatory friendly. Meet us at BioEurope for an introductory discussion. We are sponsoring the 16th World Vaccine Congress Europe 2015 […]


ExpreS2 platform licensed by Boston Children’s Hospital

The execution with Boston Children’s Hospital, located in Boston, Massachusetts, USA, of a non-exclusive research license agreement to use ExpreS2ion’s proprietary recombinant protein expression platform ExpreS2 for Boston Children’s academic research. Boston Children’s is the pediatric teaching affiliate of Harvard Medical School. Read the PR


News Archive

March 2015 A vaccine against placental malaria made with ExpreS2ion® Biotechnologies protein expression technology, ExpreS2, is ready to start human tests in Germany and Benin. Placental malaria vaccine to start human tests in Germany and Benin February 2015 ExpreS2ion® Biotechnologies licenses the ExpreS2 system to the Gene Center in Munich, […]